Swiss National Bank Cytokinetics Inc Call Options Transaction History
Swiss National Bank
- $150 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
406Shares Held
125MCall Options Held
4.6MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$543 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$447 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$359 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$298 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.35B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...